We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Thc2.5
Tetrahydrocurcumin Research
Mostly mechanism / observational
21 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Tetrahydrocurcumin studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from medium-quality randomised trials published 2006–2026 with a typical study size of 19 participants.
Based on 21 studies · 1 RCT · 29 total participants
Confidence
Low confidence
By outcome
Neuroprotection & brain agingNeuroprotective and mood signals come from animal studies. The one 19-person adjunct pilot found no difference in depression scores. Not established · Unknown
Mostly mechanism / observational4 studies
Cognitive function
Too few graded studies2 studies
Heart & blood pressure
Too few graded studies2 studies
Glucose & metabolic
Too few graded studies2 studies
Depression & mood
Too few graded studies1 study
Energy & fatigue
Too few graded studies1 study
Inflammation
Too few graded studies1 study
Digestive health
Too few graded studies1 study
5 more outcomes with fewer studies not shown.
Active research area
14 studies in the last 5 years
200620162026
1Review2020
In plain English: While this study aimed to show curcumin as a promising potential solution for eye conditions and discusses the involved mechanistic pathways, further work is required for the clinical application of curcumin.
Kao YW et al. · International journal of molecular sciences (2020)
Nevertheless, studies of THC in eye diseases have not yet been conducted.
Since ophthalmic conditions play a crucial role in worldwide public health, the prevention and treatment of ophthalmic diseases are of great concern.
Therefore, the present study investigated the antioxidative, anti-inflammatory, antiangiogenic, and neuroprotective effects of THC on four major ocular diseases: age-related cataracts, glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR).
In plain English: Thus, curcumin holds promise as a multifaceted agent in the management of obesity and associated diseases.
Cerullo M, Armeli F, Mengoni B, Menin M, Crudeli ML, Businaro R. · Nutrients (2025)
Additionally, curcumin modulates oxidative stress by activating the NRF2 pathway, enhancing cellular antioxidant defenses.
Emerging evidence also supports curcumin's potential in improving gut health by modulating microbiota composition, enhancing intestinal barrier function, and reducing systemic inflammation.
This interaction with the gut-brain axis highlights the broader implications of curcumin in neuroprotection, as it positively affects cognitive function and mitigates neuroinflammation in neurodegenerative diseases like Alzheimer's. disease.
In plain English: Research on THC's therapeutic application must focus on improving delivery and bioavailability and confirming its clinical safety and efficacy.
Zeng A, Quan Y, Tao H, Dai Y, Song L, Zhao J, Zhao J. · International journal of molecular sciences (2025)
Tetrahydrocurcumin (THC), a curcumin derivative, shows potential in oncology and neurology.
It regulates NF-κB, reduces inflammation, promotes cancer cell apoptosis, inhibits tumor angiogenesis, and enhances antioxidants, aiding in treating inflammation-related cancers.
In neurology, THC's anti-inflammatory and antioxidant properties protect neurons, reduce neuroinflammation, and support autophagy for cellular debris clearance, with its blood-brain barrier penetration offering a neuroprotective edge.
In plain English: Thus, the present review has been aimed to highlight different molecular pathways involved in the amelioration of hypertension and associated conditions.
Joshi P et al. · Molecular and cellular biochemistry (2022)
In the current scenario, hypertension is considered as a key risk factor due to its involvement in various pathogeneses.
Thus, the present review has been aimed to highlight different molecular pathways involved in the amelioration of hypertension and associated conditions.
In plain English: Increasing evidence confirmed that THC had a wide range of biological activities and significant treatment effects on diseases.
Zhou M et al. · Food & Function (2024)
Review of THC's research progress in neurological disorders, metabolic syndromes, cancers, and inflammatory diseases.
Effects are mediated by MAPK, JAK/STAT, NF-κB, Nrf2, PI3K/Akt/mTOR, AMPK, and Wnt/β-catenin signalling.
The authors state THC has higher bioavailability and stability than curcumin, and discuss its pharmacokinetics, drug combinations and toxicology as a basis for developing supplements and drugs.
In plain English: Whether THC is superior to curcumin on a molecular level is unclear and thus is the focus of this review.
Aggarwal BB et al. · Molecules (2014)
Mechanistic review directly comparing curcumin and its metabolite THC.
Curcumin (but not THC) binds and inhibits numerous molecular targets, and inhibits tumour-cell growth and viral cell entry much more effectively than THC.
Other studies, however, suggest that THC is superior to curcumin for induction of GSH peroxidase, glutathione-S-transferase, NADPH: quinone reductase, and quenching of free radicals.
In plain English: Notably, curcumin metabolites exhibit activity comparable to, or even exceeding, the therapeutic potential of the parent compound in models of glucose and lipid metabolism disorders.
Liu F et al. · The American Journal of Chinese Medicine (2026)
Systematic review of curcumin's reduced metabolites, including tetrahydrocurcumin, and their regulation of glucose and lipid homeostasis via PPARα, NF-κB, and PI3K/AKT.
The authors propose that part of curcumin's metabolic activity may be carried by its metabolites, given curcumin's low oral bioavailability.
The evidence it describes is preclinical, and the abstract cites no human trial of THC.
In plain English: This work could enhance our understanding toward health-promoting properties of spice compounds as well as provide new insights into the prevention and treatment of disorders associated with mitochondrial dysfunctions by those nutraceuticals.
Han L, Ho CT, Lu M. · Journal of agricultural and food chemistry (2025)
In this review, the role of mitochondria in maintaining cellular and metabolism homeostasis is summarized.
The regulatory effects of mitochondrial function by major bioactive compounds from natural spices are evaluated, including capsaicin, 6-gingerol, 6-shogaol, allicin, quercetin, curcumin, tetrahydrocurcumin, and cinnamaldehyde.
The underlying molecular mechanisms are also discussed.
In plain English: This review discusses the formulations designed to enhance bioavailability, metabolism of curcumin, relationships between solubility and particle size relative to bioavailability, human pharmacokinetic studies involving formulated curcumin products, the widely used but inappropriate practice of hydrolyzing plasma samples for quantification of blood curcumin, current applications of curcumin and its metabolites and promising directions for health maintenance and applications.
Stohs SJ et al. · Molecules (Basel, Switzerland) (2020)
However, its poor solubility and poor absorption in the free form in the gastrointestinal tract and its rapid biotransformation to inactive metabolites greatly limit its utility as a health-promoting agent and dietary supplement.
Recent advances in micro- and nano-formulations of curcumin with greatly enhanced absorption resulting in desirable blood levels of the active forms of curcumin now make it possible to address a wide range of potential applications, including pain management, and as tissue protective.
Using these forms of highly bioavailable curcumin now enable a broad spectrum of appropriate studies to be conducted.
In plain English: Building on existing research, future research should focus on large-scale clinical trials and advanced multi-omics studies to uncover the potential of TCM in managing T2DM through the gut microbiota.
Bibi A, Zhou L, You M, Niu H, Tasleem MW, Wu H, Zhang H. · The American journal of Chinese medicine (2026)
It also discusses the therapeutic potential of TCM, which includes natural medicinal extracts like baicalin, berberine, tetrahydrocurcumin, ginsenoside Rb1, ophiopogonin D, and resveratrol, compound formulations, and acupuncture, in regulating the intestinal microbiota ecosystem to manage T2DM.
Although the current evidence suggests that these interventions may slow T2DM progression, most studies have been confined to animal models and early clinical trials which lack adequate clinical evidence to confirm their efficacy.
This discrepancy has created an imbalance between theoretical and validated clinical applications.
In plain English: This work highlights the need for carefully designed, long-term studies to better understand how curcumin and its bioactive metabolites work, their safety, and their effectiveness.
Lagoa R, Rajan L, Violante C, Babiaka SB, Marques-da-Silva D, Kapoor B, Reis F, Atanasov AG. · Biotechnology advances (2025)
Furthermore, the exploration of drug-laden scaffolds and dermal delivery may extend the pharmacological applications of curcumin.
Recent advancements in delivery systems, particularly brain-targeting nanocarriers like polymersomes, micelles, and liposomes, have shown promise in enhancing curcumin's bioavailability and therapeutic efficacy in animal models.
Studies reviewed here indicate that engineered dermal formulations and devices could serve as viable alternatives for neuroprotective treatments and to manage skin or musculoskeletal inflammation.
In plain English: THC significantly attenuated agonist-induced granule secretion in human gel-filtered platelets in vitro ... leading to a decrease in thromboxane A2 generation.
Li W et al. · Thrombosis and Haemostasis (2022)
Human platelets in vitro plus a mouse thrombosis model: THC inhibited platelet granule secretion and thromboxane A2 generation via cPLA2/MAPK signalling.
In mice, THC and curcumin attenuated thrombus growth without prolonging the tail bleeding time.
THC did not further decrease the inhibitory effects of aspirin on thrombosis formation.
In plain English: THC ameliorated nonalcoholic steatohepatitis induced by high-fat diet by restoring hepatocyte lipophagy through the mTORC1-TFEB signaling pathway.
Wu J et al. · Biomedicine & Pharmacotherapy (2024)
Rat NASH model plus palmitate-stimulated liver cells: THC effectively improved hepatic steatosis, inflammation and oxidative stress in NASH rats, and reduced lipid accumulation in the cells.
THC restored lipophagy to reduce lipid accumulation by regulating mTORC1-TFEB pathway in NASH rats and steatosis hepatocytes.
Preclinical liver and metabolic evidence, not yet tested in humans.
In plain English: Tetrahydrocurcumin ... resulted a significant reduction in blood glucose and significant increase in plasma insulin in diabetic rats, which proved its antidiabetic effect.
Murugan P, Pari L. · Basic & Clinical Pharmacology & Toxicology (2006)
Diabetic-rat study: oral THC (80 mg/kg, 45 days) lowered blood glucose, raised insulin, and reduced lipid peroxidation and serum and tissue lipids.
Tetrahydrocurcumin showed a better effect when compared with curcumin.
In plain English: THC augmentation improved gastrointestinal symptoms in patients (p = 0.025), though total HAMD scores showed no significant group differences.
Guo Y et al. · Molecular Neurobiology (2025)
A randomized, open-label pilot in 19 patients with major depressive disorder: escitalopram 10 mg/day alone or with 200 mg/day THC for 29 days, with blinded raters. Sixteen completed the primary assessment.
THC augmentation improved gastrointestinal symptoms in patients (p = 0.025), though total HAMD scores showed no significant group differences.
The antidepressant-like effects and serum protein changes come mostly from a parallel mouse stress model.